patents

Facing slowing performance and a halved stock price, Novo Nordisk's CFO stated that the key to the future lies in next-generation weight loss drugs.

① Facing competition from rivals eroding its market share, Danish pharmaceutical giant Novo Nordisk... ① The company is...

Stock
2026-01-12